InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (hospitals & Transplant services, research & academic institutes, and independent reference laboratories.)- Market Outlook And Industry Analysis 2031”
The Global Transplant Diagnostics Market is estimated to reach over USD 8.26 billion by 2031, exhibiting a CAGR of 7.7% during the forecast period.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1760
The rise in stem cell-based, soft tissue, and solid transplantation, the increase in the prevalence of chronic diseases, the expansion of laboratory automation of diagnostic procedures assisted by robots, and technological advancements in human leukocyte antigen typing are just a few of the significant factors driving the growth of the global Transplant Diagnostics Market.
Further factors driving the expansion of the global Transplant Diagnostics Market include an increase in public and private investments in the creation of novel human leukocyte antigen (HLA) products for testing, the exponential growth of HLA diagnostic applications, improvements in healthcare infrastructure, particularly in developing nations, a steady decline in the average cost of gene sequencing and expanding NGS and PCR instrument installation bases.
According to the Owners of leading organizations, the market is being driven by increased organ transplant procedures, technological advancements, the incidence of chronic diseases, and more R&D activity. However, the market expansion is constrained by the need for suitable organs for transplant procedures, challenges with HLA sequencing, and widespread ignorance. The sector now making the most money is consumables. The SMEs assert that transplant diagnostics costs are increasing due to the increased demand for organ transplants.
Furthermore, the majority of transplant diagnostic makers and distributors focus more on expanding markets due to their potential. The primary reason for the increased attention on emerging nations is the rising burden of chronic diseases in these countries.
List of Prominent Players in the Transplant Diagnostics Market:
- Abbott Laboratories, Inc.
- Adaptive Biotechnologies
- Affymetrix, Inc.
- altona Diagnostics GmbH
- Arquer Diagnostics Ltd
- BAG Diagnostics GmbH
- Becton, Dickinson and Company,
- Biofortuna Limited
- BioMerieux SA,
- Bio-rad Laboratories, Inc.
- Biotype GmbH
- CareDx Inc.
- CLONIT srl
- Diagnóstica Longwood SL
- DiaSorin S.p.A.
- EUROFINS VIRACOR
- Hoffmann La-Roche AG.
- Hologic, Inc.
- Horiba Ltd
- Illumina, Inc.
- Immucor Transplant Diagnostics, Inc.
- Laboratory Corporation of America Holdings.
- Linkage Biosciences
- Luminex Corporation
- Merck KGaA
- Olerup SSP AB
- Omixon Ltd.
- Preservation Solutions, Inc.
- Qiagen N.V.
- Randox Laboratories Ltd.
- Takara Bio Inc.
- Thermo Fisher Scientific,
- Zimmer Biomet
The market for transplant diagnostics is being driven by the rising rates of organ failure caused by acute diseases, which are also increasing the demand for transplant treatments. A successful organ transplant is a complex procedure that depends on the recipient’s body’s ability to absorb the donor’s organ. Transplant diagnostic tests are carried out to see if organ transplants can be effective. The United Network for Organ Sharing, a non-profit organisation based in the US that oversees organ transplantation in the country, estimates that in 2021, organ transplants in the country will reach a record high. In 2021, there were 3,817 heart transplants, 24,669 liver transplants, and 9,236 kidney transplants. The growing demand for diagnostic tests is driving the market for transplant diagnostics.
A substantial disparity between the demand for organ transplantation and organ donation is holding back the market for transplant diagnostics. Organ transplantation needs are outpacing the number of organ donors by an increasing margin. 106,090 persons were on the waiting list to receive organ donations in 2021, according to the Health Resources and Services Administration. A growing number of patients on the waiting list for organ transplants is causing a massive shortage between the supply and demand of organ donors. The market growth is being restrained by the limited number of organ donors, which is limiting the need for transplant diagnostic tests and technologies.
The Global Transplant Diagnostics Market is divided into six regions based on geography: North America, Latin America, Middle East & Africa, Europe, Asia Pacific, and the Rest of the World. North America holds a leading position in the global market for transplant diagnostics as a result of the region’s solid organ-based transplantation, growing stem cell population, private-public funding for the development of HLA typing technology, and ongoing average cost reduction of gene sequencing. The Asia Pacific region’s China and India will have the fastest growth rates in the worldwide transplant diagnostics market over the next five years.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/report/transplant-diagnostics-market/1760
- In March 2022, Immucor, Inc., a business specialising in transfusion and transplantation diagnostics, introduced two new products to its transplant diagnostics line, proving its dedication to recent developments in the histocompatibility industry.
Segmentation of Transplant Diagnostics Market-
- Molecular assay technologies
- PCR based molecular assays
- Real-time PCR
- Sequence-specific primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based molecular assays
- Sequencing based molecular assays
- Sanger sequencing
- Next generation sequencing
- Non molecular assays technologies
By Product & Service-
- Reagents & Consumables
- Software & Services
- Diagnostic Application
- Infectious Disease Testing
- Histocompatibility Testing
- Blood Profiling
- Post-Transplantation Diagnostics
- Research Applications
By Transplant Type-
- Solid organ transplantation
- Stem Cell Transplantation
- Soft Tissue Transplantation
- Bone Marrow Transplantation
- Hospitals & Transplant Centers
- Research & Academic Institutes
- Independent Research Laboratories
- The US
- The UK
- Rest of Europe
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/1760
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Site Visit: https://www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/
InsightAce Analytic Pvt. Ltd. Tel.: +1 551 226 6109 Email: firstname.lastname@example.org Site Visit: https://www.insightaceanalytic.com Follow Us on LinkedIn @ bit.ly/2tBXsgS Follow Us On Facebook @ bit.ly/2H9jnDZ Follow Us @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/ Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/